| URN | urn:agi-llid:2113 |
|---|---|
| Total Entities | 0 |
| Connectivity | 626 |
| Name | Ets1 |
| Description | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
| Notes | This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011] |
| Ariadne Ontology | Ets |
|---|---|
| Oncogenes | |
| Secreted proteins | |
| Biofluids assayable substances |
| GO Molecular Function | transcription factor binding |
|---|---|
| DNA binding | |
| sequence-specific DNA binding | |
| sequence-specific DNA binding transcription factor activity |
| GO Cellular Component | transcription factor complex |
|---|---|
| nucleus |
| GO Biological Process | female pregnancy |
|---|---|
| negative regulation of cell cycle | |
| regulation of extracellular matrix disassembly | |
| positive regulation of transcription, DNA-dependent | |
| positive regulation of transcription from RNA polymerase II promoter | |
| regulation of transcription, DNA-dependent | |
| regulation of transcription from RNA polymerase II promoter | |
| negative regulation of cell proliferation | |
| negative regulation of apoptotic process | |
| positive regulation of cell proliferation | |
| positive regulation of cellular component movement | |
| positive regulation of cell migration | |
| positive regulation of erythrocyte differentiation | |
| induction of apoptosis | |
| transcription, DNA-dependent | |
| transcription from RNA polymerase II promoter | |
| cell motility | |
| cellular response to hydrogen peroxide | |
| PML body organization | |
| immune response | |
| response to estradiol stimulus | |
| response to interleukin-1 | |
| response to antibiotic | |
| response to hypoxia | |
| response to wounding | |
| response to laminar fluid shear stress | |
| response to mechanical stimulus | |
| positive regulation of angiogenesis | |
| angiogenesis involved in wound healing | |
| hypothalamus development | |
| pituitary gland development | |
| estrous cycle phase |
| Pathway | ERBB2/3 -> EP300/ETS/ETV/SP1 signaling |
|---|---|
| BTC/EP300/ETS/ETV/SP1 Expression Targets | |
| NRG1/EP300/ETS/ETV/SP1 Expression Targets | |
| FGF2/AP-1/CREB/CREBBP/ELK-SRF/MYC Expression Targets | |
| FGF2/STAT Expression Targets | |
| EGF/AP-1/ATF Expression Targets | |
| EGF/STAT Expression Targets | |
| TGFB1-ACVRL1 Expression Targets | |
| TGFB1-TGFBR1/AP-1 Expression Targets | |
| IL1B Expression Targets | |
| EGF/CTNN Expression Targets | |
| altered p53 signaling pathway |
| Group | Ets |
|---|---|
| Oncogenes | |
| female pregnancy | |
| negative regulation of cell cycle | |
| regulation of extracellular matrix disassembly | |
| positive regulation of transcription, DNA-dependent | |
| positive regulation of transcription from RNA polymerase II promoter | |
| regulation of transcription, DNA-dependent | |
| regulation of transcription from RNA polymerase II promoter | |
| negative regulation of cell proliferation | |
| negative regulation of apoptotic process | |
| positive regulation of cell proliferation | |
| positive regulation of cellular component movement | |
| positive regulation of cell migration | |
| positive regulation of erythrocyte differentiation | |
| induction of apoptosis | |
| transcription, DNA-dependent | |
| transcription from RNA polymerase II promoter | |
| cell motility | |
| cellular response to hydrogen peroxide | |
| PML body organization | |
| immune response | |
| response to estradiol stimulus | |
| response to interleukin-1 | |
| response to antibiotic | |
| response to hypoxia | |
| response to wounding | |
| response to laminar fluid shear stress | |
| response to mechanical stimulus | |
| positive regulation of angiogenesis | |
| angiogenesis involved in wound healing | |
| hypothalamus development | |
| pituitary gland development | |
| estrous cycle phase | |
| transcription factor binding | |
| DNA binding | |
| sequence-specific DNA binding | |
| sequence-specific DNA binding transcription factor activity | |
| transcription factor complex | |
| nucleus | |
| Secreted proteins | |
| Biofluids assayable substances |
| MedScan ID | 2113 |
|---|
| Hugo ID | 3488 |
|---|
| Human chromosome position | 11q23.3 |
|---|
| LocusLink ID | 2113 |
|---|---|
| 23871 | |
| 24356 |
| Alias | ETS-1 |
|---|---|
| EWSR2 | |
| protein C-ets-1 | |
| p54 | |
| ets protein | |
| v-ets avian erythroblastosis virus E2 oncogene homolog 1 | |
| Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1 | |
| Tpl1 | |
| AI196000 | |
| AI448617 | |
| D230050P06 | |
| C-ets-1 protein (p54) | |
| tumor progression locus 1 | |
| avian erythroblastosis virus E26 oncogene 1 | |
| Etsoncb | |
| Ets avian erythroblastosis virus E2 oncogene homolog 1 (tumor progression locus 1) | |
| MGC130355 | |
| MGC18571 | |
| v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | |
| p42Ets-1 | |
| MGC124638 | |
| p51Ets-1 | |
| Tp11 | |
| Tpl I | |
| tumor progression locus I | |
| tumour progression locus 1 | |
| tumour progression locus I | |
| v-ets avian erythroblastosis virus E2 oncogene homolog I | |
| v-ets avian erythroblastosis virus E26 oncogene homolog 1 | |
| v-ets erythroblastosis virus E26 oncogene homolog 1 | |
| v-ets erythroblastosis virus E26 oncogene homolog I | |
| LOC270138 | |
| v-ets avian erythroblastosis virus E26 oncogene homolog I | |
| LOC235150 | |
| E26 avian leukemia oncogene 1, 5' domain | |
| Avian erythroblastosis virus E26 (v-ets) oncogene homolog I | |
| C-ETS-1 | |
| C-ETS-1 proteins | |
| E26 avian leukaemia oncogene 1, 5' domain | |
| Ets avian erythroblastosis virus E2 oncogene homolog 1 (tumour progression locus 1) | |
| ets avian erythroblastosis virus e2 oncogene homolog I | |
| FLJ10768 | |
| Ets I | |
| ETS1 | |
| ets avian erythroblastosis virus e2 oncogene homolog 1 | |
| Etsoncbs |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| OMIM ID | 164720 |
|---|
| Unigene ID | Hs.369438 |
|---|---|
| Mm.292415 | |
| Rn.88756 |
| KEGG ID | hsa:2113 |
|---|---|
| mmu:23871 | |
| rno:24356 |
| Swiss-Prot Accession | P14921 |
|---|---|
| A8K725 | |
| B4DW78 | |
| F5GYX9 | |
| E9PWI8 | |
| Q8K3Q9 | |
| P27577 | |
| Q540Q5 | |
| Q8BVW8 | |
| P41156 | |
| Q61403 | |
| Q3T1H1 | |
| Q14278 | |
| Q16080 | |
| Q6N087 |
| GO ID | 0003677 |
|---|---|
| 0043565 | |
| 0003700 | |
| 0008134 | |
| 0030578 | |
| 0060055 | |
| 0048870 | |
| 0070301 | |
| 0060206 | |
| 0007565 | |
| 0021854 | |
| 0006955 | |
| 0006917 | |
| 0045786 | |
| 0008285 | |
| 0021983 | |
| 0045766 | |
| 0030335 | |
| 0008284 | |
| 0051272 | |
| 0045648 | |
| 0045944 | |
| 0045893 | |
| 0010715 | |
| 0046677 | |
| 0032355 | |
| 0001666 | |
| 0070555 | |
| 0034616 | |
| 0009612 | |
| 0006366 | |
| 0006351 | |
| 0005634 | |
| 0005667 | |
| 0006357 | |
| 0006355 | |
| 0009611 | |
| 0006916 |
| PIR ID | A30487 |
|---|---|
| I48291 | |
| A53988 | |
| A32066 |
| Swiss-Prot ID | ETS1_MOUSE |
|---|---|
| ETS1_RAT | |
| ETS1_HUMAN |
| Cell Localization | Nucleus |
|---|
| IPI ID | IPI00117744 |
|---|---|
| IPI00475631 | |
| IPI00028127 | |
| IPI00218351 | |
| IPI00742887 |
| Mouse chromosome position | 9 15.0 cM |
|---|
| Rat chromosome position | 8q21 |
|---|
| Homologene ID | 3837 |
|---|
| MGI ID | 95455 |
|---|
| RGD ID | 2583 |
|---|
| Primary Cell Localization | Nucleus |
|---|